Management of moderate and severe ovarian hyperstimulation syndrome: a Canadian Fertility and Andrology Society clinical practice guideline
Reproductive BioMedicine Online · 2026-06 · 52 (6) · 105541
DOI: 10.1016/j.rbmo.2026.105541 ↗Kurz gefasst
Leitlinie in der Zeitschrift Reproductive BioMedicine Online, 2026-06. Verfasst von William Buckett und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, McGill University, Quebec, Canada. Electronic addres…. Hauptthemen laut MEDLINE: Ovarian Hyperstimulation Syndrome, Ovulation Induction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Ovarian hyperstimulation syndrome (OHSS) is a potentially serious complication associated with ovarian stimulation for assisted reproductive technology. While measures to prevent and reduce the incidence of OHSS are part of good clinical practice, OHSS still occurs, and patients may present to clinicians with varying familiarity with the condition. Diagnosis is largely clinical, although radiological and laboratory testing helps determine the severity of the syndrome. Management of moderate and severe OHSS is primarily supportive as either an outpatient or an inpatient and may include paracentesis. Critical OHSS needs hospitalization and multidisciplinary care. This clinical practice guideline assesses the published evidence regarding the diagnosis and management of patients presenting with moderate and severe OHSS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, McGill University, Quebec, Canada. Electronic address: William.buckett@mcgill.ca.
- Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, University of Montreal, and Clinique OVO Fertilité, Montreal, Quebec, Canada.
- Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.
- The Montreal Fertility Centre, Montréal, Quebec, Canada.
- Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Calgary, and Regional Fertility Program, Calgary, Alberta, Canada.
- Pacific Centre for Reproductive Medicine, and Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of British Columbia, Vancouver, British Columbia, Canada.
Zitieren
APA
Buckett, W., Sylvestre, C., Liu, K., Mahutte, N., Min, J., Roberts, J., Saumet, J., Shapiro, H., Sierra, S., & Velez, M. P. (2026). Management of moderate and severe ovarian hyperstimulation syndrome: a Canadian Fertility and Andrology Society clinical practice guideline. Reproductive BioMedicine Online, 52(6), 105541. https://doi.org/10.1016/j.rbmo.2026.105541
Vancouver
Buckett W, Sylvestre C, Liu K, Mahutte N, Min J, Roberts J, et al. Management of moderate and severe ovarian hyperstimulation syndrome: a Canadian Fertility and Andrology Society clinical practice guideline. Reproductive BioMedicine Online. 2026;52(6):105541. doi:10.1016/j.rbmo.2026.105541
BibTeX
@article{Buckett2026,
author = {Buckett, William and Sylvestre, Camille and Liu, Kimberly and Mahutte, Neal and Min, Jason and Roberts, Jeff and Saumet, Julio and Shapiro, Heather and Sierra, Sony and Velez, Maria P},
title = {Management of moderate and severe ovarian hyperstimulation syndrome: a Canadian Fertility and Andrology Society clinical practice guideline},
journal = {Reproductive BioMedicine Online},
year = {2026},
volume = {52},
number = {6},
pages = {105541},
doi = {10.1016/j.rbmo.2026.105541}
}
EUVIMED